Crawford Healthcare, one of the biggest makers of advanced wound-care products in the UK, has won clearance from US regulators for a medical dressing that it says will “save limbs”.
The product, called KerraCel AG, soaks up fluid and bacteria from nasty, oozing wounds and locks it away as a gel. It is also the only dressing of its kind to contain silver at a special concentration to kill all bacteria – even those resistant to antibiotics – that prevent chronic wounds, such as diabetic ulcers and pressure sores, from healing.
The stamp of approval from the US Food and Drug Administration (FDA) is a coup for Cheshire-based Crawford and its chief executive Richard Anderson, who says the US wound care market will be worth more than $12bn (£9.63bn) by next year.
Read more at The Telegraph
